Skip to main content
SpringerLink
Log in

The Authors’ Reply

  • Correspondence
  • Published:
CNS Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yang R, Mao S, Li R, et al. The need to develop more sensitive tools to accurately detect clinical response to treatment in ADHD [letter]. CNS Drugs 2012; 26(2): 185–6

    Article  PubMed  Google Scholar 

  2. Mazzone L, Reale L, Mannino V, et al. Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder. CNS Drugs 2011; 25(6): 503–9

    Article  PubMed  Google Scholar 

  3. Posey DJ, Wiegand RE, Wilkerson J, et al. Open-label atomoxetine for attention-deficit/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol 2006 Oct; 16(5): 599–610

    Article  PubMed  Google Scholar 

  4. Jain R, Babcock T, Burtea T, et al. Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. Child Adolesc Psychiatry Ment Health 2011 4; 5(1): 35

    Article  PubMed  Google Scholar 

  5. Kratochvil CJ, Vaughan BS, Stoner JA, et al. A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics 2011; 127(4): e862–8

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to prepare this letter. The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Division of Child Neurology and Psychiatry, Department of Neuroscience, Children’s Hospital Bambino Gesù, Rome, Italy

    Luigi Mazzone

  2. Child and Adolescent Treatment and Preventive Intervention Research Branch, National Institute of Mental Health, Bethesda, MD, USA

    Benedetto Vitiello

Authors
  1. Luigi Mazzone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benedetto Vitiello
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mazzone, L., Vitiello, B. The Authors’ Reply. CNS Drugs 26, 186–187 (2012). https://doi.org/10.2165/11630100-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11630100-000000000-00000

Keywords

Search

Navigation